» Articles » PMID: 36814699

White Matter Lesions Predominantly Located in Deep White Matter Represent Embolic Etiology Rather Than Small Vessel Disease

Overview
Date 2023 Feb 23
PMID 36814699
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: We investigated the correlation between the deep distribution of white matter hyperintensity (WMH) (dWMH: WMH in deep and corticomedullary areas, with minimal periventricular WMH) and a positive agitated saline contrast echocardiography result.

Methods: We retrospectively recruited participants with comprehensive dementia evaluations, an agitated saline study, and brain imaging. The participants were classified into two groups according to WMH-distributions: dWMH and dpWMH (mainly periventricular WMH with or without deep WMH.) We hypothesized that dWMH is more likely associated with embolism, whereas dpWMH is associated with small-vessel diseases. We compared the clinical characteristics, WMH-distributions, and positive rate of agitated saline studies between the two groups.

Results: Among 90 participants, 27 and 12 met the dWMH and dpWMH criteria, respectively. The dWMH-group was younger (62.2±7.5 vs. 78.9±7.3, <0.001) and had a lower prevalence of hypertension (29.6% vs. 75%, =0.008), diabetes mellitus (3.7% vs. 25%, =0.043), and hyperlipidemia (33.3% vs. 83.3%, =0.043) than the dpWMH-group. Regarding deep white matter lesions, the number of small lesions (<3 mm) was higher in the dWMH-group(10.9±9.7) than in the dpWMH-group (3.1±6.4) (=0.008), and WMH was predominantly distributed in the border-zones and corticomedullary areas. Most importantly, the positive agitated saline study rate was higher in the dWMH-group than in the dpWMH-group (81.5% vs. 33.3%, =0.003).

Conclusions: The dWMH-group with younger participants had fewer cardiovascular risk factors, showed more border-zone-distributions, and had a higher agitated saline test positivity rate than the dpWMH-group, indicating that corticomedullary or deep WMH-distribution with minimal periventricular WMH suggests embolic etiologies.

Citing Articles

Heme Oxygenase-1 Gene (GT)n Polymorphism Linked to Deep White Matter Hyperintensities, Not Periventricular Hyperintensities.

Chen J, Li J, Wang X, Fu X, Ke J, Li J J Am Heart Assoc. 2024; 13(11):e033981.

PMID: 38818928 PMC: 11255616. DOI: 10.1161/JAHA.123.033981.

References
1.
Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein H, Vermersch P . Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry. 1992; 55(10):967-72. PMC: 1015202. DOI: 10.1136/jnnp.55.10.967. View

2.
Wardlaw J, Allerhand M, Doubal F, Hernandez M, Morris Z, Gow A . Vascular risk factors, large-artery atheroma, and brain white matter hyperintensities. Neurology. 2014; 82(15):1331-8. PMC: 4001185. DOI: 10.1212/WNL.0000000000000312. View

3.
Yoon C, Choi Y, Jeon S, Lee D, Yoon B, Park H . Is antiplatelet treatment effective at attenuating the progression of white matter hyperintensities?. PLoS One. 2017; 12(4):e0176300. PMC: 5398663. DOI: 10.1371/journal.pone.0176300. View

4.
Greenberg S, Vernooij M, Cordonnier C, Viswanathan A, Salman R, Warach S . Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol. 2009; 8(2):165-74. PMC: 3414436. DOI: 10.1016/S1474-4422(09)70013-4. View

5.
Lee P, Song J, Kim J, Heo R, Lee S, Kim D . Cryptogenic Stroke and High-Risk Patent Foramen Ovale: The DEFENSE-PFO Trial. J Am Coll Cardiol. 2018; 71(20):2335-2342. DOI: 10.1016/j.jacc.2018.02.046. View